Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.52
Delayed Data
As of 3:59pm ET
 +0.06 / +1.73%
Today’s Change
2.44
Today|||52-Week Range
10.60
-59.63%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Alnylam Pharmaceuticals Inc
Sale2/23/20161,000,000$7.18$7.2M-49.79%
Foletta Mark G
Director
Buy8/13/201510,000$7.64$76.4K-52.11%
Hagan Joseph P
Chief Operating Officer
Buy3/03/201610,000$7.19$71.9K-51.04%
Papadopoulos Stelios B
Director
Buy8/07/201515,677$2.66$41.7K-49.57%
Papadopoulos Stelios B
Director
Buy8/07/201517,500$1.74$30.5K-49.57%
Papadopoulos Stelios B
Director
Buy8/07/201517,500$0.38$6.7K-49.57%